Sabby Management’s 9 Meters Biopharma NMTR Stock Holding History

Sabby Management’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-543	Closed	-$68.4K	–	132
2022 Q4	$68.4K	Buy	543 +516	+1,911%	+$1.18K	0.06%	82
2022 Q3	$12K	Sell	27 -124	-82%	-$615	0.02%	108
2022 Q2	$79K	Buy	151 +72	+91%	+$678	0.05%	89
2022 Q1	$687K	Sell	79 -19	-19%	-$259	0.1%	56
2021 Q4	$192K	Sell	98 -85	-46%	-$1.9K	0.03%	135
2021 Q3	$475K	Buy	183 +140	+326%	+$3.3K	0.06%	117
2021 Q2	$95K	Buy	+43	New	+$1.06K	0.01%	150

Sabby Management's NMTR Position: Q4 2023 in Review

Sabby Management sold out of 9 Meters Biopharma (NMTR) in Q4 2023, closing a stake of 1,672,627 shares — an estimated $20.1K sold.

Sabby Management first reported a position in NMTR in Q2 2019 and held it in 7 quarters. The position peaked at $1.55M in Q2 2019. 1 fund tracked by Wall St. Rank holds NMTR as of Q4 2023.

Sabby Management reported no remaining 9 Meters Biopharma position as of Q4 2023 after selling out during the quarter.
Sabby Management sold 1,672,627 9 Meters Biopharma shares in Q4 2023, an estimated $20.1K.
Sabby Management first reported a position in 9 Meters Biopharma in Q2 2019 and held it in 7 quarters.
Sabby Management's 9 Meters Biopharma position peaked at $1.55M in Q2 2019.
1 fund tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2023.

Based on Sabby Management's 13F filing for Q4 2023, filed 14 Feb 2024.